- Forums
- ASX - By Stock
- Ann: Impressive Bisantrene Phase 2 AML Clinical Results
Actually looks reasonable [ATTACH]
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.62 |
Change
-0.115(6.65%) |
Mkt cap ! $284.5M |
Open | High | Low | Value | Volume |
$1.74 | $1.74 | $1.61 | $221.1K | 134.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 17194 | $1.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.64 | 791 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 17194 | 1.610 |
1 | 550 | 1.605 |
4 | 3562 | 1.600 |
1 | 3184 | 1.595 |
1 | 1082 | 1.585 |
Price($) | Vol. | No. |
---|---|---|
1.640 | 791 | 1 |
1.675 | 10200 | 2 |
1.680 | 2500 | 1 |
1.715 | 791 | 1 |
1.730 | 27032 | 1 |
Last trade - 13.37pm 27/08/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online